Omnicell (OMCL) Net Income towards Common Stockholders (2010 - 2026)
Omnicell's (OMCL) quarterly Net Income towards Common Stockholders came in at $11.4 million in Q1 2026, up 261.73% year-on-year from $3.1 million in Q1 2025, and up 647.64% on a QoQ basis from -$2.1 million in Q4 2025.
Omnicell (OMCL) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Omnicell (OMCL) has 17 years of Net Income towards Common Stockholders data on file, last reported at $11.4 million in Q1 2026.
- On a quarterly basis, Net Income towards Common Stockholders rose 261.73% year-over-year to $11.4 million in Q1 2026; TTM through Mar 2026 was $20.4 million, a 3.77% decrease from a year earlier, with the FY2025 full-year figure at $2.1 million, down 83.62% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at $11.4 million, up from -$2.1 million in the prior quarter.
- Over the last five years, Net Income towards Common Stockholders for OMCL reached as high as $16.8 million in Q3 2022 and fell as low as -$28.4 million in Q4 2022.
- Historically, Net Income towards Common Stockholders has averaged $657823.5 across 5 years, with a median of $5.5 million in 2025.
- Across the five-year window, Net Income towards Common Stockholders plunged 303.19% in 2022 and soared 261.73% in 2026, its largest moves.
- Year by year, Net Income towards Common Stockholders stood at -$28.4 million in 2022, then soared by 49.38% to -$14.4 million in 2023, then surged by 210.17% to $15.8 million in 2024, then tumbled by 113.09% to -$2.1 million in 2025, then surged by 647.64% to $11.4 million in 2026.
- Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were $11.4 million in Q1 2026, -$2.1 million in Q4 2025, and $5.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 32.15 Bn | 24.84 Bn | 662.02 Mn | 260.94 Mn |
| 2 | BrightSpring Health Services | 14.66 Bn | 13.75 Bn | 482.22 Mn | 148.77 Mn |
| 3 | Healthequity | 8.39 Bn | 8.13 Bn | 256.31 Mn | 69.42 Mn |
| 4 | Hinge Health | 5.95 Bn | 5.64 Bn | 154.23 Mn | 34.01 Mn |
| 5 | 10x Genomics | 5.88 Bn | 5.34 Bn | 106.18 Mn | -13.47 Mn |
| 6 | MiniMed | 4.53 Bn | 4.23 Bn | 480.00 Mn | -185.00 Mn |
| 7 | Waystar Holding | 4.46 Bn | 4.40 Bn | 216.84 Mn | 43.28 Mn |
| 8 | Doximity | 3.96 Bn | 3.21 Bn | 125.97 Mn | 19.11 Mn |
| 9 | Privia Health | 3.13 Bn | 2.71 Bn | - | 3.71 Mn |
| 10 | Omnicell | 1.88 Bn | 1.64 Bn | 140.36 Mn | 11.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.36 Mn |
| Dec 31, 2025 | -2.07 Mn |
| Sep 30, 2025 | 5.46 Mn |
| Jun 30, 2025 | 5.64 Mn |
| Mar 31, 2025 | -7.02 Mn |
| Dec 31, 2024 | 15.84 Mn |
| Sep 30, 2024 | 8.63 Mn |
| Jun 30, 2024 | 3.74 Mn |
| Mar 31, 2024 | -15.68 Mn |
| Dec 31, 2023 | -14.38 Mn |
| Sep 30, 2023 | 5.55 Mn |
| Jun 30, 2023 | 3.45 Mn |
| Mar 31, 2023 | -14.98 Mn |
| Dec 31, 2022 | -28.41 Mn |
| Sep 30, 2022 | 16.77 Mn |
| Jun 30, 2022 | 9.07 Mn |
| Mar 31, 2022 | 8.21 Mn |
| Dec 31, 2021 | 13.98 Mn |
| Sep 30, 2021 | 29.32 Mn |
| Jun 30, 2021 | 20.42 Mn |